Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 1: Predicting Degradation Related Impurities and Impurity Considerations for Pharmaceutical Dosage Forms

被引:19
作者
Alsante, Karen M. [1 ]
Huynh-Ba, Kim [2 ]
Baertschi, Steven W. [3 ]
Reed, Robert A. [4 ]
Landis, Margaret S. [1 ]
Kleinman, Mark H. [5 ]
Foti, Christopher [1 ]
Rao, Venkatramana M. [6 ]
Meers, Paul [7 ]
Abend, Andreas [8 ]
Reynolds, Daniel W. [9 ]
Joshi, Biren K. [9 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
[2] Pharmalytik, Newark, DC USA
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[4] Celsion Corp, Lawrenceville, NJ USA
[5] GlaxoSmithKline, King Of Prussia, PA USA
[6] Bristol Myers Squibb, New Brunswick, NJ USA
[7] Rutgers State Univ, New Brunswick, NJ 08903 USA
[8] Merck, West Point, PA USA
[9] GlaxoSmithKline, Res Triangle Pk, NC USA
关键词
CHEMICAL HYDROLYSIS; GAS-CHROMATOGRAPHY; EXCIPIENTS; STABILITY; PHOTOSTABILITY; LIPOSOMES; IDENTIFICATION; PHOSPHOLIPIDS; PHOTOTOXICITY; FORMULATIONS;
D O I
10.1208/s12249-013-0047-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:198 / 212
页数:15
相关论文
共 58 条
[1]  
Abend A, 2010, AM PHARM REV, V25, P201
[2]  
Abend A, 2011, DRUGS PHARM SCI, V210, P322
[3]  
Al- Badr A. A., 1983, ANAL PROFILES DRUG S, P385
[4]  
Albini A, 2004, PHOTOSTABILITY OF DR
[5]   The role of degradant profiling in active pharmaceutical ingredients and drug products [J].
Alsante, Karen M. ;
Ando, Akemi ;
Brown, Roland ;
Ensing, Janice ;
Hatajik, Todd D. ;
Kong, Wei ;
Tsuda, Yoshiko .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) :29-37
[6]  
Alsante KM, 2012, FORCED DEGRADATION F
[7]  
Alsante KM, 2012, SCIENTIFIC COMPUTING, P30
[8]  
[Anonymous], 2009, INTERNATIONAL CONFER
[9]  
[Anonymous], 2003, INTERNATIONAL CONFER
[10]   Analytical methodologies for discovering and profiling degradation-related impurities [J].
Baertschi, Steven W. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2006, 25 (08) :758-767